Tootsie Roll Industries (TR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual Meeting scheduled for May 6, 2026, to elect six directors, ratify the appointment of Grant Thornton LLP as auditor, and hold an advisory vote on executive compensation.
Shareholders of record as of March 5, 2026, are entitled to vote, with Common Stock carrying one vote per share and Class B Common Stock ten votes per share.
The Gordon family controls over 50% of voting power, qualifying the company as a “controlled company” under NYSE rules.
Voting matters and shareholder proposals
Proposals include election of six directors, ratification of Grant Thornton LLP as auditor for 2026, and a non-binding advisory vote on executive compensation for 2025.
Shareholder proposals for the 2027 meeting must be received by November 27, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
Board consists of six directors, with a mix of family members and independent directors; non-management directors (except one) are independent under NYSE standards.
Board combines Chairman and CEO roles; no lead independent director.
Board reviews succession planning and has adopted Corporate Governance Guidelines and a Code of Business Conduct and Ethics.
Board does not have a separate nominating committee due to controlled company status; director nominations are handled by the full Board.
Latest events from Tootsie Roll Industries
- 2025 earnings rose on higher sales and margin recovery, with input costs and tariffs easing ahead.TR
Q4 202512 Feb 2026 - Annual meeting to elect directors and ratify auditor, with board oversight and controlled voting.TR
Proxy Filing2 Dec 2025 - Q3 2025 saw higher sales, earnings, and margins, but input costs and tariffs remain risks.TR
Q3 20257 Nov 2025 - Q2 sales and earnings rose, but margin risks from cocoa costs and tariffs persist.TR
Q2 20258 Aug 2025 - Q3 sales fell nearly 10%, but margins and EPS improved; cocoa costs and pension risks persist.TR
Q3 202413 Jun 2025 - Earnings and EPS rose despite lower sales, but margin pressure from high cocoa costs is expected.TR
Q2 202413 Jun 2025 - Earnings rose 14% despite lower sales, but margin pressure from cocoa costs is expected ahead.TR
Q1 20256 Jun 2025 - Adjusted for tax effects, profit grew despite sales declines and rising input costs.TR
Q4 20245 Jun 2025